To further investigate the association of circulating betatrophin concentration with glucose and lipid metabolism, we measured betatrophin concentrations in subjects of newly-diagnosed T2DM, normal glucose tolerance (NGT) and impaired glucose tolerance (IGT) and analyzed the relationship between betatrophin and related clinical parameters. This evidence concerns the gene ANGPTL8 and Impaired glucose tolerance.